Page last updated: 2024-10-26

valproic acid and Autosomal Dominant Cerebellar Ataxia, Type II

valproic acid has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 2 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Research Excerpts

ExcerptRelevanceReference
" We identified a patient with a positive family history for episodic ataxia, who was originally diagnosed with epilepsy and treated with valproic acid."3.73CACNA1A mutation in a EA-2 patient responsive to acetazolamide and valproic acid. ( Bulman, DE; Friedman, JH; Scoggan, KA, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scoggan, KA1
Friedman, JH1
Bulman, DE1
Kanai, K1
Sakakibara, R1
Uchiyama, T1
Liu, Z1
Yamamoto, T1
Ito, T1
Hirano, S1
Asahina, M1
Kuwabara, S1
Hattori, T1
Fukami, G1
Arai, K1
Yamaguchi, C1
Nomura, F1

Other Studies

2 other studies available for valproic acid and Autosomal Dominant Cerebellar Ataxia, Type II

ArticleYear
CACNA1A mutation in a EA-2 patient responsive to acetazolamide and valproic acid.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2006, Volume: 33, Issue:1

    Topics: Acetazolamide; Adult; Amino Acid Sequence; Animals; Anticonvulsants; Calcium Channels; Diagnosis, Di

2006
Sporadic case of spinocerebellar ataxia type 17: treatment observations for managing urinary and psychotic symptoms.
    Movement disorders : official journal of the Movement Disorder Society, 2007, Feb-15, Volume: 22, Issue:3

    Topics: Anticonvulsants; Electromyography; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Psychotic

2007